Intrathecal analgesia for refractory cancer pain

Scott Newsome, Bridget K. Frawley, Charles E. Argoff

Research output: Contribution to journalReview articlepeer-review

Abstract

The use of intrathecal analgesics is an important treatment consideration for many patients with chronic cancer pain. This review describes the various opioid and nonopioid analgesics that have been used in this setting, including morphine, hydromorphone, fentanyl, meperidine, methadone, sufentanil, local anesthetics, clonidine, ketamine, baclofen, midazolam, betamethasone, and octreotide. We discuss available evidence for their analgesic and adverse effects.

Original languageEnglish (US)
Pages (from-to)249-256
Number of pages8
JournalCurrent pain and headache reports
Volume12
Issue number4
DOIs
StatePublished - 2008
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Intrathecal analgesia for refractory cancer pain'. Together they form a unique fingerprint.

Cite this